Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

SpaceX IPO Shocks Wall Street: Is This the Biggest Investment of the Decade?

Keith Snyder, Senior Equity Analyst at CFRA, explains what's driving investor demand for SpaceX and whether the excitement is justified.

Big Business This Week: Is the Coming IPO Wave a Financial Trap?

Do the numbers add up?

SpaceX Takes Center Stage as Wall Street Eyes the Next Big Market Catalyst

Phil Rosen, Chief Market Strategist at ProCap Financial, discusses the growing anticipation around a SpaceX IPO and Oracle's AI-driven growth.

The Race to Build America’s Drone Delivery Network Is Officially Underway

Matternet CEO Andreas Raptopoulos discusses the future of drone delivery, U.S. manufacturing, FAA regulations and industry competition.

Who Will Control the Future of Driverless Cars?

Seth Goldstein, Senior Equity Analyst and Chair of the Electric Vehicle Committee at Morningstar, breaks down the robotaxi race and EV adoption trends.

Why the Next Space Revolution May Be About Power, Not Rockets

Andrew Rush, CEO of Star Catcher Industries, joins us to discuss how wireless power transmission could reshape satellite technology and space communications.

How Siri Is About to Get a Whole Lot Smarter

Apple unveils a smarter Siri and major AI updates. Mark Spoonauer, Global Editor-in-Chief at Tom’s Guide, breaks down WWDC 2026.

How to Build a Career That Survives the AI Revolution

As AI reshapes the workforce, author Benjamin Todd explains how graduates can build resilient, fulfilling careers and thrive in a changing job market.

The GLP-1 Effect: How Weight-Loss Drugs Are Changing the Business of Healthcare

America's GLP-1 boom is reshaping healthcare. SHARx co-founder Paul Pruitt explains who pays, why costs are surging, and what comes next.

Experian's AI Strategy Is Reshaping Financial Services

From Money 20/20, Experian UK & Ireland CEO Malin Holmberg discusses the trends, opportunities and innovations shaping fintech's future.

Load More